Confronto

Selank vs. Teduglutid

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

129954-34-3

197922-42-2

Peso molecolare

751.85 g/mol

3752.13 g/mol

Emivita

0.3 h

nessun dato

Sequenza

Thr-Lys-Pro-Arg-Pro-Gly-Pro

nessun dato

Meccanismo d'azione

Selank

Selank is a glyproline-tuftsin analog. Proposed mechanisms include modulation of the GABAergic system, effects on serotonin bioavailability, and influence on enkephalinases. Animal studies show anxiolytic and neuroprotective markers; a clear receptor target is not established.

Teduglutid

Teduglutide activates the GLP-2 receptor, promoting growth and regeneration of small-intestinal villi, increasing nutrient and fluid absorption and thereby reducing dependence on parenteral nutrition. The glycine substitution at position 2 makes it resistant to rapid breakdown by DPP-4.

Base di evidenze

Evidenza più alta

Studio sull'uomo

RCT sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Selank	Teduglutid
Germania	Non approvato	Su prescrizione
RU	Su prescrizione	—
Stati Uniti	Non approvato	Su prescrizione

Voci complete

Frequently asked questions

What is the difference between Selank and Teduglutid?: Selank is classified as "Ricerca (altro)", while Teduglutid is classified as "Ricerca (altro)". Selank: Synthetic heptapeptide derived from natural tuftsin. Approved as an anxiolytic (Selank) in Russia and some CIS states. Western phase-3 trials are absent; efficacy assessment relies on Russian research literature. Teduglutid: Teduglutide is a DPP-4-resistant analog of GLP-2 (glucagon-like peptide-2). It promotes growth and function of the intestinal mucosa and is approved for treating short bowel syndrome. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Selank or Teduglutid?: The highest available evidence level is "Studio sull'uomo" for Selank and "RCT sull'uomo" for Teduglutid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Selank and Teduglutid in Germany and the United States?: Germania: Selank — Non approvato, Teduglutid — Su prescrizione. Stati Uniti: Selank — Non approvato, Teduglutid — Su prescrizione. These are factual summaries with source and review date on the individual pages.

Country

Selank

Teduglutid

Germania

Non approvato

Su prescrizione

—

Stati Uniti

Non approvato

Su prescrizione

Frequently asked questions

What is the difference between Selank and Teduglutid?

Selank is classified as "Ricerca (altro)", while Teduglutid is classified as "Ricerca (altro)". Selank: Synthetic heptapeptide derived from natural tuftsin. Approved as an anxiolytic (Selank) in Russia and some CIS states. Western phase-3 trials are absent; efficacy assessment relies on Russian research literature. Teduglutid: Teduglutide is a DPP-4-resistant analog of GLP-2 (glucagon-like peptide-2). It promotes growth and function of the intestinal mucosa and is approved for treating short bowel syndrome. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Selank or Teduglutid?

The highest available evidence level is "Studio sull'uomo" for Selank and "RCT sull'uomo" for Teduglutid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Selank and Teduglutid in Germany and the United States?

Germania: Selank — Non approvato, Teduglutid — Su prescrizione. Stati Uniti: Selank — Non approvato, Teduglutid — Su prescrizione. These are factual summaries with source and review date on the individual pages.